For laboratory research use only. Not for human consumption.
CJC-1295 For Sale
A synthetic research compound developed for controlled laboratory environments.
Modified GRF 1-29
Dosage
Quantity
Bundle & Save
From
$29.99Type
Research Peptide
Category
Peptides
Batch
SBP-001
Batch number
SBP-001
Tested date
4/7/2026
What is CJC-1295?
CJC-1295 (Modified GRF 1-29) is offered as a research reference material for qualified analytical and in vitro laboratory workflows. CJC-1295 is manufactured under controlled conditions to ensure consistency across batches. Designed strictly for laboratory and analytical research applications. For laboratory research use only. Not for human consumption.
How it Works
In research settings, CJC-1295 is used to probe defined biological pathways under controlled laboratory conditions. Mechanistic studies typically combine receptor or cell-based assays with analytical verification of peptide identity and integrity.
Purity & Testing
98.9% minimum purity (per specification / COA for the active batch). Each lot is tied to batch documentation so researchers can align material received with COA and specification records before use in regulated workflows. Request a COA from this page if you need documentation prior to purchase.
Storage & Handling
Store lyophilized material per label and COA. Solvent selection and working-solution preparation must follow institutional laboratory SOPs.
Research Overview
A synthetic research compound developed for controlled laboratory environments.
Specifications
| Compound | Modified GRF 1-29 |
|---|---|
| Presentation | 2mg |
| purity | High Purity |
| storage | Refrigerated (2-8C recommended) |
| CAS | 863288-34-0 |
| Purity | 98.9% |
| Catalog reference period | 90 days |
Sources & References
Peer-reviewed research
Journal of Clinical Endocrinology & Metabolism
Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults
2006 · DOI: 10.1210/jc.2005-1536 · PMID: 16384850
Teichman SL, Neale A, Lawrence B, Gagnon C, Castaigne JP, Frohman LA
View SourceJournal of Endocrinology
Growth hormone-releasing hormone (GHRH) analogs
2009 · DOI: 10.1677/JOE-09-0210 · PMID: 19577563
Sackmann-Sala L, Ding J, Frohman LA, Kopchick JJ
View SourceEndocrinology
Synthetic analogues of growth hormone-releasing hormone with antagonistic activity
2001 · DOI: 10.1210/endo.142.10.8454 · PMID: 11564718
Schally AV, Varga JL
View SourceThe Journal of clinical endocrinology and metabolism
Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults
2006 · DOI: 10.1210/jc.2005-1536 · PMID: 16352683
Teichman SL, Neale A, Lawrence B, et al.
View SourceAmerican journal of physiology. Endocrinology and metabolism
Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, normalizes growth in the GHRH knockout mouse
2006 · DOI: 10.1152/ajpendo.00201.2006 · PMID: 16822960
Alba M, Fintini D, Sagazio A, et al.
View SourceFrequently Asked Questions
- What is CJC-1295 without DAC?
- CJC-1295 (no DAC) is a growth hormone-releasing hormone analog studied in secretagogue research models. Our listing is for laboratory research only.
- Why choose CJC-1295 for sale from Science Based Peptides?
- We provide clear specifications, batch traceability, and COA support so researchers can document material identity before experiments.
- How does CJC-1295 differ from the ipamorelin blend?
- The blend combines CJC-1295 with ipamorelin in one SKU for multi-compound protocols. Single-compound SKUs isolate each peptide for controlled studies.
- Is CJC-1295 research-use only?
- Yes. All catalog peptides are sold for qualified in vitro / laboratory research under our terms of use.
Related Products
Request Certificate of Analysis (COA)
Need documentation for this product? Submit your name and email and we will send COA details.